Target intelligence / Profile preview

RAB12 antisense RNA 1 (RAB12-AS1)

Target
RAB12-AS1
Molecular classification
Long non-coding RNA, Natural antisense transcript, Other
01

Overview

RAB12 antisense RNA 1 (RAB12-AS1) is a long non-coding RNA (lncRNA) that acts as a natural antisense transcript to the protein-coding RAB12 gene. Long non-coding antisense RNAs typically regulate the expression of their sense gene counterparts through mechanisms such as transcriptional interference, formation of RNA–RNA duplexes, modulation of RNA stability, or inhibition of translation[6]. Antisense RNAs can act in *cis* (affecting neighboring genes on the same DNA strand) or *trans* (affecting distant genes). While there is biological precedent for antisense regulation impacting many cellular processes, there are no direct studies on the specific biological function, disease association, or therapeutic targeting of RAB12-AS1 as of current knowledge[6]. No information exists for RAB12-AS1 as a drug target, nor are there known interacting drugs or mechanisms of action, and it is not used as a biomarker in clinical settings. Note: - RAB12-AS1 should not be confused with RAB12, which is a small GTPase with functions in vesicle trafficking and autophagy, and is protein-coding[1][5][7]. - RAB12-AS1 is not a therapeutic target, but it may be of research interest in gene expression regulation studies involving natural antisense transcripts[6].

Other names
RAB12-AS1RAB12 antisense RNA 1
02

Biological functions

Regulation of gene expressionTranscriptional interferencePost-transcriptional regulation
03

Disease associations

Other (potential gene expression modulation; insufficient evidence for role in specific diseases as of current knowledge)

Beyond the preview

Go deeper on RAB12 antisense RNA 1 (RAB12-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB12 antisense RNA 1 (RAB12-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call